Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study

• Main Authors: L. A. Tashireva (Author), N. O. Popova (Author), V. V. Alifanov (Author), V. E. Goldberg (Author), E. I. Kovalenko (Author), E. V. Artamonova (Author), A. G. Manikhas (Author), D. M. Ponomarenko (Author), N. V. Levchenko (Author), E. I. Rossokha (Author), S. Yu. Krasilnikova (Author), M. A. Zafirova (Author), V. M. Perelmuter (Author)
• Format: Book
• Published: ABV-press, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Triple negative breast cancer has no specific treatment sites for chemotherapy and is unfavorable in terms of prognosis. One of the drugs widely used in this cohort of patients is eribulin, which in addition to its antimitotic effect has an effect on the tumor microenvironment. The searc...